[Clinical implications of antibiotic resistance of enterococci].
Besnier
J M
JM
Service de Maladies infectieuses, Hôpital Bretonneau, Tours.
Leport
C
C
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002511:Cephalosporins / Q000494:pharmacology; D003428:Cross Infection / Q000382:microbiology / Q000517:prevention & control; D004352:Drug Resistance, Microbial; D013293:Enterococcus faecalis / Q000187:drug effects*; D006020:Glycopeptides / Q000494:pharmacology; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D012307:Risk Factors
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D006020:Glycopeptides